1-Bromo-4-(trifluoromethoxy)benzene → HCID 19040924, compound
Reaction equation
[S:1]1[CH:5]=[CH:4][CH:3]=[C:2]1[CH2:6][N:7]1[CH2:12][CH2:11][CH:10]([C:13]([O:15]CC)=O)[CH2:9][CH2:8]1.[F:18][C:19]([F:29])([F:28])[O:20][C:21]1[CH:26]=[CH:25][C:24](Br)=[CH:23][CH:22]=1.[Mg]>O1CCCC1.CC(C)=O.C(Cl)Cl>[S:1]1[CH:5]=[CH:4][CH:3]=[C:2]1[CH2:6][N:7]1[CH2:8][CH2:9][CH:10]([C:13]([C:24]2[CH:23]=[CH:22][C:21]([O:20][C:19]([F:18])([F:28])[F:29])=[CH:26][CH:25]=2)([C:24]2[CH:25]=[CH:26][C:21]([O:20][C:19]([F:29])([F:28])[F:18])=[CH:22][CH:23]=2)[OH:15])[CH2:11][CH2:12]1Participants
Procedure
This compound was prepared in a manner analogous to that of Step B of Example 3, with 2.0 grams (0.008 mole) of ethyl N-(thien-2-ylmethyl)piperidin-4-ylcarboxylate, 3.5 mL (0.024 mole) of 4-trifluoromethoxyphenyl bromide, and 0.6 gram (0.025 gram-atom) of magnesium turnings in about 69 mL of tetrahydrofuran as reagents. The crude reaction product was subjected to column chromatography on silica gel, with pure methylene chloride, 9:1 methylene chloride:acetone, pure acetone, and then 8:2 methylene chloride:acetone as eluants. The product-containing fractions were combined and concentrated under reduced pressure, yielding about 0.2 gram of N-(thien-2-ylmethyl)-4-[bis(4-trifluoromethoxyphenyl)hydroxymethyl]piperidine. The NMR spectrum was consistent with the proposed structure.
Workup
- customThis compound was prepared in a manner analogous to that of Step B of Example 3
- customThe crude reaction product
- concentrationconcentrated under reduced pressure
Sources & evidence
- ORD record
- ord-0b4dfeb2292242cbbc852add7b738d1a
- Source dataset
- uspto-grants-1996_10
- Patent number
- US05569664
Reaction notes
Loading…